Blog | StemoniX

Matt Green, neurons, and AAV

Welcome to StemoniX, Matt! Tell us a bit about your research background. I have worked in quite a few academic labs dating back to when I...

Your partners in discovery

How StemoniX and vivoPharm can help you predict the biological effects of your compounds.

Seeing is Believing – A Sneak Peek into StemoniX microBrain Platforms

Organoid scale - How big is a microBrain? StemoniX specializes in growing human iPSC-derived co-cultures of neurons and astrocytes in...

Q&A with Our Newest Team Members

For this month’s blog, our two newest scientists kindly agreed to answer some questions. We are so thrilled to have these two scientists...

Staying Human to Drive Successful Transitions

In the Fall of 2020, StemoniX announced plans to merge with Cancer Genetics, bringing into focus two different and very complementary...

High Hopes from Tiny Brains

From a small number of precursor cells and following numerous divisions, migration, and differentiation, the human brain emerges with a...

IPSCs – THE BASICS

StemoniX was conceived by co-founder and current CEO Ping Yeh. Ping, a survivor of non-Hodgkin’s Lymphoma, was inspired to find new ways...